MedTrace Logo

Transversus Abdominus Plane Block in Living Donor Hepatectomy

NCT02708459 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2016-08-30

No results posted yet for this study

Summary

Comparing different drugs used in Transversus abdominus plane analgesia after donor hepatectomy. Patients will be divided into three groups; control group, Bupivecaine group, and Dexmedetomedine group according to the used drug

Conditions

  • Living Donor Hepatectomy

Interventions

DEVICE

surgically inserted Transversus abdominus plane catheter

at end of surgery, a surgeon will insert catheter in Transversus abdominus plane (TAP) between internal oblique muscle and Transversus abdominus muscle

DRUG

Intravenous morphine

Boluses of intravenous morphine (2 mg) will be given to patients if Visual analogue scale (VAS) more than 3

DRUG

Bupevecaine

DRUG

Dexmedetomedine

Sponsors & Collaborators

  • AlRefaey Kandeel

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2016-08-31
Completion
2016-08-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02708459 on ClinicalTrials.gov